The global health challenge presented by Human Immunodeficiency Virus (HIV) necessitates innovative strategies to combat the virus and improve treatment outcomes. This research explores the potential of gamma-delta (γδ) T cells in HIV control, specifically focusing on the less-explored aspects of their functionality and untapped therapeutic capabilities. The paper provides a comprehensive review of current literature on γδ T cells, highlighting their distinctive features and their role in bridging innate and adaptive immune responses. Furthermore, the study delves into recent advancements in unraveling the elusive characteristics of these cells and their potential contribution to HIV control. The outcomes of this research propose promising avenues for harnessing γδ T cells in the ongoing efforts to combat HIV.
No takes yet. Share an insight, caveat, or question.
Isabella Rossi (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: